⌘K

Home/Filings/4/0001209191-24-003025

4//SEC Filing

Lind Kevin Robert 4

Accession 0001209191-24-003025

CIK 0001832168other

View on SEC.gov Company Profile

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 4:06 PM ET

Size

8.7 KB

Accession

0001209191-24-003025

Insider Transaction Report

Form 4

Period: 2024-02-08

Longboard Pharmaceuticals, Inc.LBPH

Lind Kevin Robert

DirectorPresident and CEO

Transactions

Award
Stock Option (Right to Buy)
2024-02-08+332,134→ 332,134 total
Exercise: $19.32Exp: 2034-02-07→ Voting common stock (332,134 underlying)

Footnotes (1)

[F1]The shares subject to the stock option vest and become exercisable in 48 equal monthly installments commencing March 8, 2024.

Documents

2 files

Issuer

Longboard Pharmaceuticals, Inc.

CIK 0001832168

Entity typeother

Related Parties

1

filerCIK 0001677036

Filing Metadata

Form type: 4
Filed: Feb 8, 7:00 PM ET
Accepted: Feb 9, 4:06 PM ET
Size: 8.7 KB

View on SEC.gov